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Abstract
Among various possible causes of autoimmune disease, an important role is played by infections
that can result in a breakdown of immune tolerance, primarily through the mechanism of “molecular
mimicry”. In this paper we propose and analyse a stochastic model of immune response to a viral
infection and subsequent autoimmunity, with account for the populations of T cells with different
activation thresholds, regulatory T cells, and cytokines. We show analytically and numerically
how stochasticity can result in sustained oscillations around deterministically stable steady states,
and we also investigate stochastic dynamics in the regime of bi-stability. These results provide
a possible explanation for experimentally observed variations in the progression of autoimmune
disease. Computations of the variance of stochastic fluctuations provide practically important
insights into how the size of these fluctuations depends on various biological parameters, and this
also gives a headway for comparison with experimental data on variation in the observed numbers
of T cells and organ cells affected by infection.
1 Introduction
Breakdown of immune tolerance and the resulting autoimmune disease occur when the immune system
fails to distinguish the host’s own healthy cells from the cells affected by the infection, thus triggering
an immune response that also targets healthy cells. Autoimmune disease is usually focused in a specific
organ or part of the body, such as retina in the case of uveitis, central nervous system in multiple
sclerosis, or pancreatic β-cells in insulin-dependent diabetes mellitus type-1 [1, 2, 3]. Whilst it is close
to impossible to pinpoint precise causes of autoimmunity in each individual case, it can usually be
attributed to a number of factors, which can include the genetic predisposition, age, previous immune
challenges, exposure to pathogens etc. A number of distinct mechanisms have been identified for how
an infection of the host with a pathogen can result in the subsequent onset of autoimmune disease, and
these include bystander activation [4] and molecular mimicry [5, 6], which is particularly important
in the context of autoimmunity caused by viral infections.
Over the years, a number of mathematical models have investigated various origins and aspects of
immune response, with an emphasis on the onset and the development of autoimmune disease. Some
of the earlier models studied interactions between regulatory and effector T cells without looking at
causes of autoimmunity but instead focusing on T cell vaccination [7]. Borghans et al. [8, 9] looked into
this process in more detail and showed the onset of autoimmunity, which was defined as oscillations
in the number of autoreactive cells that exceeded a certain threshold. Leo´n et al. [10, 11, 12] and
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Carneiro et al. [13] have analysed interactions between different T cells and their effect on regulation
of immune response and control of autoimmunity. More recently, Iwami et al. [14, 15] considered
a model of immune response to a viral infection, in which they explicitly included the dynamics of
a virus population. Although this model is able to demonstrate an emergence of autoimmunity, it
fails to produce a regime of normal viral clearance. Alexander and Wahl [16] have focused on the
role of professional antigen-presenting cells (APCs) and their interactions with regulatory and effector
cells for the purposes of controlling autoimmune response. Burroughs et al. [17, 18] have analysed
the emergence of autoimmunity through the mechanism of cytokine-mediated bystander activation.
A special issue on “Theories and modelling of autoimmunity” provides an excellent overview of re-
cent research in the area of mathematical modelling of various aspects of onset and development of
autoimmune disease [19].
These are several different frameworks for modelling the role of T cells in controlling autoimmune
response. Alexander and Wahl [16] and Burroughs et al. [17, 18] have explicitly included a separate
compartment for regulatory T cells that are activated by autoantigens and suppress the activity of
autoreactive T cells. Another modelling approach is to consider the possibility of the same T cells
performing different immune functions through having different or tunable activation thresholds, which
allows T cells to adjust their response to T cell antigen receptor stimulation by autoantigens. This
methodology was originally proposed theoretically to study peripheral and central T cell activation [20,
21, 22], and has been subsequently used to analyse differences in activation/response thresholds that
are dependent on the activation state of the T cell [23]. van den Berg and Rand [24] and Scherer et
al. [25] have studied stochastic tuning of activation thresholds. Interestingly, the need for T cells to
have tunable activation can be shown to emerge from the fundamental principles of of signal detection
theory [26]. A number of murine and human experiments have confirmed that activation of T cells
can indeed dynamically change during their circulation [27, 28, 29, 30], thus supporting the theory
developed in earlier papers.
Since immune response is known to be a complex multi-factor process [31], a number of studies have
looked into various stochastic aspects of immune dynamics, such as T cell selection and proliferation.
Deenick et al. [32] have analysed stochastic effects of interleukin-2 (IL-2) on T cell proliferation
from precursors. Blattman et al. [33] have shown that repertoires of the CTL (cytotoxic T cell
lymphocyte) populations during primary response to a viral infection and in the memory pool are
similar, thus providing further support to the theory of stochastic selection for the memory pool.
Detours and Perelson [34] have explored the distribution of possible outcomes during T cell selection
with account for variable affinity between T cell receptors and MHC-peptide complexes. Chao et
al. [35] analysed a detailed stochastic model of T cell recruitment during immune response to a
viral infection. Stirk et al. [36, 37] have developed a stochastic model for T cell repertoire and
investigated the role of competitive exclusion between different clonotypes. Using the methodology
of continuous-time Markov processes, the authors computed extinction times, a limited multivariate
probability distribution, as well as the size of fluctuations around the deterministic steady states.
Reynolds [38] have used a similar methodology to investigate an important question of asymmetric
cell division and its impact on the extinction of different T cell populations and the expected lifetimes
of na¨ıve T cell clones. With regards to modelling autoimmune dynamics, Alexander and Wahl [16]
have studied the stochastic model of immune response with an emphasis on professional APCs to show
that the probability of developing a chronic autoimmune response increases with the initial exposure
to self-antigen or autoreactive effector T cells. An important aspect of stochastic dynamics that has
to be accounted for in the models is the so-called stochastic amplification [39, 40], which denotes a
situation where periodic solutions with decaying amplitudes in the deterministic model can result in
sustained stochastic periodic oscillations in individual realisations of the same model. This suggests
that whilst on average the behaviour may show decaying-amplitude oscillations, individual realisations
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represented by stochastic oscillations can explain relapses/remissions in clinical manifestations of the
disease as caused by endogenous stochasticity of the immune processes.
Blyuss and Nicholson [41, 42] have proposed and analysed a mathematical model of immune
response to a viral infection that explicitly takes into account the populations of two types of T cells
with different activation thresholds and also allows for infection and autoimmune response to occur
in different organs. This model supports the regimes of normal viral clearance, a chronic infection,
and an autoimmune state represented by exogenous oscillations in cell populations, associated with
episodes of high viral production followed by long periods of quiescence. Such behaviour, that in the
clinical observation could be associated with relapses and remissions, has been observed in a number
of autoimmune diseases, such as MS, autoimmune thyroid disease and uveitis [43, 44, 45]. Despite its
successes, this model has a limitation that the periodic oscillations are only possible when the amount
of free virus and the number of infected cells are also exhibiting oscillations, while in laboratory and
clinical situations, one rather observes a situation where the initial infection is completely cleared,
and this is then followed by the onset of autoimmune reaction. To overcome this limitation, Fatehi et
al. (2017) have recently extended the model of Blyuss and Nicholson to also include the population
of regulatory T cells and the cytokine mediating T cell activity.
In this paper we analyse the effects of stochasticity on the dynamics of immune response in a model
with the populations of T cells with different activation thresholds, regulatory cells and cytokines,
as presented in Methods. Starting with a system of ordinary differential equations, we apply the
methodology of continuous-time Markov chains (CTMC) to derive a Kolmogorov, or chemical master
equation, describing the dynamics of a probability distribution of finding the system in a particular
state. To make further analytical and numerical progress, we derive an Itoˆ stochastic differential
equation, whose solutions provide similar stochastic paths to those of the CTMC models. This then
allows us to numerically study the stationary multivariate probability distributions for the states in
the model, explore stochastic amplification, determine how the magnitude of stochastic fluctuations
around deterministic steady states depends on various parameters, and investigate the effects of initial
conditions on the outcome in the case of bi-stability between different dynamical states. These results
suggest that the experimentally observed variation in the progression of autoimmune disease can
be attributed to stochastic amplification, and they also provide insights into how the variance of
fluctuations depends on parameters, which can guide new laboratory experiments.
2 Methods
2.1 Continuous-time Markov chain model of immune dynamics
In a recent paper we introduced and analysed a deterministic model for autoimmune dynamics with
account for the populations of T cells with different activation thresholds and cytokines (Fatehi et
al. 2017). The analysis showed that depending on parameters and initial conditions, the model can
support the regimes of normal disease clearance, where an initial infection is cleared without further
consequences for immune dynamics, chronic infection characterised by a persistent presence of infected
cells in the body, and the state of autoimmune behaviour where after clearance of initial infection, the
immune system supports stable endogenous oscillations in the number of autoreactive T cells, which
can be interpreted in the clinical practice of autoimmune disease as periods of relapses and remissions.
This work extended earlier results on modelling the effects of tunable activation thresholds [41, 42] by
including regulatory T cells, as well as the cytokine mediating proliferation and activity of different
types of T cells.
A deterministic model for immune response to a viral infection, as illustrated in a diagram shown
in Figure 1, has the form
3
Figure 1: A schematic diagram of immune response to infection. Blue indicates host cells (susceptible
and infected), red denotes T cells (na¨ıve, regulatory, normal activated, and autoreactive), yellow shows
cytokines (interleukin-2).
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dS
dt
= rS
(
1− S
N
)
− βSF − µaTautS,
dF
dt
= βSF − dFF − µFTnorF − µaTautF,
dTin
dt
= λin − dinTin − αTinF,
dTreg
dt
= λr − drTreg + p1αTinF + ρ1ITreg,
dTnor
dt
= p2αTinF − dnTnor + ρ2ITnor,
dTaut
dt
= (1− p1 − p2)αTinF − daTaut − δTregTaut + ρ3ITaut,
dI
dt
= σ1Tnor + σ2Taut − diI,
(1)
where S(t) is the number of susceptible organ cells, F (t) is the number of infected cells, Tin(t) is
the number of na¨ıve T cells, Treg(t) is the number of regulatory T cells, Tnor(t) is the number of
activated T cells which recognise foreign antigen and destroy infected cells, Taut(t) is the number
of autoreactive T cells which destroy cells presenting both foreign and self-antigen, and I(t) is the
amount of interleukin 2 (IL-2) cytokine. In this model, it is assumed that in the absence of infection,
organ cells in the host reproduce logistically with a linear growth rate r and carrying capacity N , and
they can become infected at rate β by already infected cells that are producing new virus particles.
Unlike earlier models [41, 42] and (Fatehi et al. 2017), we consider the situation where the process
of producing virions by infected cells is quite fast, hence, we do not explicitly incorporate a separate
compartment for free virus. Regarding immune response, we assume that na¨ıve T cells remain in
homeostasis, and upon activation at rate α by a signal from infected cells, a proportion p1 of them
will develop into regulatory T cells, a proportion p2 will become normal activated T cells able to
destroy infected cells at rate µF , and the remaining T cells will become autoreactive, in which case
their threshold for activation by susceptible cells is reduced, and hence, they will be destroying both
infected and susceptible host cells at rate µa. The effect of regulatory T cells is in reducing the number
of autoreactive T cells at rate δ, and regulatory T cells are themselves assumed to be in a state of
homeostasis. Finally, normal and autoreactive T cells produce IL-2 at rates σ1 and σ2, and IL-2 in turn
facilitates proliferation of regular, normal and autoreactive T cells at rates ρ1, ρ2 and ρ3, respectively.
One should note that in light of experimental evidence suggesting the possibility of autoimmunity in
the absence of B cells [46] and the fact that the development of antibodies can itself depend on prior
T cell activation with bacteria [47], the above model does not take into account antibody response,
but rather focuses on T cell dynamics.
As a first step in the analysis of stochastic effects in immune dynamics, we construct a CTMC
model based on the ODE model (1) using the methodology developed earlier in the context of modelling
stochastic effects in epidemic and immunological models [48, 49, 36]. To this end, we introduce
variables X1(t), . . . , X7(t) ∈ {0, 1, 2, . . .} as discrete random variables representing the number of
uninfected cells, infected cells, na¨ıve T cells, regulatory T cells, normal activated T cells, autoreactive
T cells, and interleukin-2 at time t, respectively. Let the initial condition be fixed as
X0 = (X1(0), . . . , X7(0)) = (n10, n20, n30, n40, n50, n60, n70).
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The probability of finding the system in the state n = (n1, n2, n3, n4, n5, n6, n7) with ni ∈ {0, 1, 2, ...}
at time t can be defined as
P (n, t) = Prob{X(t) = n|X(0) = X0}.
Let ∆t be sufficiently small such that ∆Xi(t) = Xi(t + ∆t) − Xi(t) ∈ {−1, 0, 1} for 1 ≤ i ≤ 7.
The CTMC can then be formulated as a birth and death process in each of the variables [48]. The
infinitesimal transition probabilities corresponding to Figure 1 are as follows,
Prob(∆X = i|X = n) =

q1∆t+ o(∆t), i = (1, 0, 0, 0, 0, 0, 0),
q2∆t+ o(∆t), i = (−1, 0, 0, 0, 0, 0, 0),
q3∆t+ o(∆t), i = (−1, 1, 0, 0, 0, 0, 0),
q4∆t+ o(∆t), i = (0, 0, 1, 0, 0, 0, 0),
q5∆t+ o(∆t), i = (0, 0,−1, 0, 0, 0, 0),
q6∆t+ o(∆t), i = (0, 0,−1, 0, 1, 0, 0),
q7∆t+ o(∆t), i = (0, 0,−1, 0, 1, 0, 0),
q8∆t+ o(∆t), i = (0, 0,−1, 0, 0, 1, 0),
q9∆t+ o(∆t), i = (0,−1, 0, 0, 0, 0, 0),
q10∆t+ o(∆t), i = (0, 0, 0, 1, 0, 0, 0),
q11∆t+ o(∆t), i = (0, 0, 0,−1, 0, 0, 0),
q12∆t+ o(∆t), i = (0, 0, 0, 0, 1, 0, 0),
q13∆t+ o(∆t), i = (0, 0, 0, 0,−1, 0, 0),
q14∆t+ o(∆t), i = (0, 0, 0, 0, 0, 1, 0),
q15∆t+ o(∆t), i = (0, 0, 0, 0, 0,−1, 0),
q16∆t+ o(∆t), i = (0, 0, 0, 0, 0, 0, 1),
q17∆t+ o(∆t), i = (0, 0, 0, 0, 0, 0,−1),
1−
17∑
i=1
qi∆t+ o(∆t), i = (0, 0, 0, 0, 0, 0, 0),
o(∆t), otherwise,
(2)
where
q1 = b1n1 + b2n
2
1, q2 = d1n1 + d2n
2
1 + µan1n6, q3 = βn1n2, q4 = λin,
q5 = dinn3, q6 = p1αn2n3, q7 = p2αn2n3, q8 = (1− p1 − p2)αn2n3,
q9 = (dF + µFn5 + µan6)n2, q10 = λr + ρ1n4n7, q11 = drn4, q12 = ρ2n5n7,
q13 = dnn5, q14 = ρ3n6n7, q15 = (da + δn4)n6, q16 = σ1n5 + σ2n6, q17 = din7.
Here, b1n1+b2n
2
1 and d1n1+d2n
2
1 are natural birth and death rates for uninfected cells with b1−d1 = r
and d2 − b2 = r/N [48].
The probabilities P (n, t) satisfy the following master equation (forward Kolmogorov equation)
dP (n, t)
dt
={(ε−1 − 1)q1 + (ε+1 − 1)q2 + (ε+1 ε−2 − 1)q3 + (ε−3 − 1)q4 + (ε+3 − 1)q5
+ (ε+3 ε
−
4 − 1)q6 + (ε+3 ε−5 − 1)q7 + (ε+3 ε−6 − 1)q8 + (ε+2 − 1)q9 + (ε−4 − 1)q10
+ (ε+4 − 1)q11 + (ε−5 − 1)q12 + (ε+5 − 1)q13 + (ε−6 − 1)q14 + (ε+6 − 1)q15
+ (ε−7 − 1)q16 + (ε+7 − 1)q17}P (n, t). (3)
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Table 1: Possible state changes ∆Y during a small time interval ∆t
i (∆Y)Ti Probability Pi∆t
1 (1, 0, 0, 0, 0, 0, 0) (b1Y1 + b2Y1
2)∆t
2 (−1, 0, 0, 0, 0, 0, 0) (d1Y1 + d2Y12 + µaY6Y1)∆t
3 (−1, 1, 0, 0, 0, 0, 0) βY1Y2∆t
4 (0, 0, 1, 0, 0, 0, 0) λin∆t
5 (0, 0,−1, 0, 0, 0, 0) dinY3∆t
6 (0, 0,−1, 1, 0, 0, 0) p1αY3Y2∆t
7 (0, 0,−1, 0, 1, 0, 0) p2αY3Y2∆t
8 (0, 0,−1, 0, 0, 1, 0) (1− p1 − p2)αY3Y2∆t
9 (0,−1, 0, 0, 0, 0, 0) (dF + µFY5 + µaY6)Y2∆t
10 (0, 0, 0, 1, 0, 0, 0) (λr + ρ1Y7Y4)∆t
11 (0, 0, 0,−1, 0, 0, 0) drY4∆t
12 (0, 0, 0, 0, 1, 0, 0) ρ2Y7Y5∆t
13 (0, 0, 0, 0,−1, 0, 0) dnY5∆t
14 (0, 0, 0, 0, 0, 1, 0) ρ3Y7Y6∆t
15 (0, 0, 0, 0, 0,−1, 0) (da + δY4)Y6∆t
16 (0, 0, 0, 0, 0, 0, 1) (σ1Y5 + σ2Y6)∆t
17 (0, 0, 0, 0, 0, 0,−1) diY7∆t
18 (0, 0, 0, 0, 0, 0, 0) 1−
17∑
i=1
Pi∆t
where the operators ε±i are defined as follows,
ε±i f(n1, n2, n3, n4, n5, n6, n7, t) = f(n1, ..., ni ± 1, ..., n7, t), for each 1 ≤ i ≤ 7,
and if ni < 0 for any 1 ≤ i ≤ 7, then P (n, t) = 0.
By solving this master equation, one can find the probability density function for this model.
However, since this is a high-dimensional difference-differential equation, solving it is a very chal-
lenging task. Normally, the number of events occurring in a small time step in the CTMC model is
extremely large, hence using the CTMC model for plotting stochastic trajectories is very computa-
tionally intensive [50]. A much more computationally efficient approach is to use chemical Langevin
equations [51, 52], also known as Itoˆ stochastic differential equation (SDE) models, which provide very
similar sample paths to those of the CTMC models [50]. While both Itoˆ and Stratonovich interpre-
tations of stochastic calculus can be applied [53], in biological applications Itoˆ formulation is more
frequently used due to its non-anticipatory nature and a closer connection to numerical implementa-
tion [54, 55, 48].
2.2 Stochastic differential equation model
To derive Itoˆ SDE model, let Y(t) = (Y1(t), Y2(t), Y3(t), Y4(t), Y5(t), Y6(t), Y7(t)) be a continuous
random vector for the sizes of various cell compartments at time t. Similar to the CTMC model, we
assume that ∆t is small enough so that during this time interval at most one change can occur in state
variables. These changes together with their probabilities are listed in Table 1, which is again based
on Figure 1 and transitions in the CTMC model (2). Using this table of possible state changes, one
can compute the expectation vector and covariance matrix of ∆Y for sufficiently small ∆t [50, 56].
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The expectation vector to order ∆t is given by
E(∆Y) ≈
17∑
i=1
Pi(∆Y)i∆t = µ∆t,
where
µ =

P1 − P2 − P3
P3 − P9
P4 − P5 − P6 − P7 − P8
P6 + P10 − P11
P7 + P12 − P13
P8 + P14 − P15
P16 − P17

is the drift vector, which can be easily seen to be identical to the right-hand side of the deterministic
model (1). The covariance matrix is obtained by keeping terms of order ∆t only, i.e.
cov(∆Y) = E
[
(∆Y)(∆Y)T
]− E [∆Y] (E [∆Y])T ≈ E [(∆Y)(∆Y)T ]
=
17∑
i=1
Pi(∆Y)i(∆Yi)
T∆t = Σ∆t,
where
Σ =

P1 + P2 + P3 −P3 0 0 0 0 0
−P3 P3 + P9 0 0 0 0 0
0 0 P4 + P5 + P6 + P7 + P8 −P6 −P7 −P8 0
0 0 −P6 P6 + P10 + P11 0 0 0
0 0 −P7 0 P7 + P12 + P13 0 0
0 0 −P8 0 0 P8 + P14 + P15 0
0 0 0 0 0 0 P16 + P17

is a 7× 7 covariance matrix. To derive Itoˆ SDE model, we need to find a diffusion matrix H defined
according to HHT = Σ. Although this matrix is not unique, different forms of this matrix give
equivalent systems [55, 56].
If one rewrites the covariance matrix Σ in the form
Σ =
U 0 00 W 0
0 0 Z
 ,
with
U =
(
P1 + P2 + P3 −P3
−P3 P3 + P9
)
, Z = P16 + P17,
and
W =

P4 + P5 + P6 + P7 + P8 −P6 −P7 −P8
−P6 P6 + P10 + P11 0 0
−P7 0 P7 + P12 + P13 0
−P8 0 0 P8 + P14 + P15
 ,
we can define three matrices H1, H2 and H3 as follows,
H1 =
(√
P1 + P2 −
√
P3 0
0
√
P3
√
P9
)
, H3 =
√
P16 + P17,
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H2 =

√
P4 + P5 −
√
P6 −
√
P7 −
√
P8 0 0 0
0
√
P6 0 0
√
P10 + P11 0 0
0 0
√
P7 0 0
√
P12 + P13 0
0 0 0
√
P8 0 0
√
P14 + P15
 .
Now if we consider
H =
H1 0 00 H2 0
0 0 H3
 ,
then HHT = Σ, where H is a 7× 11 matrix. The Itoˆ SDE model now has the form{
dY(t) = µdt+HdW(t),
Y(0) = (A(0), F (0), Tin(0), Treg(0), Tnor(0), Taut(0), I(0))
T ,
(4)
and W(t) = [W1(t),W2(t), ...,W11(t)]
T is a vector of eleven independent Wiener processes [55].
In order to make further analytical progress, we find an approximate probability density function
for the model (4) as given by an approximate solution of the master equation [55, 57]. Let P (Y, t) be
the probability density function of the model (4). Then P (Y, t) satisfies the following Fokker-Planck
equation [55, 58] which is an approximation of the master equation
∂P (Y, t)
∂t
= −
7∑
i=1
∂
∂yi
[µiP (Y, t)] +
1
2
7∑
i=1
7∑
j=1
∂2
∂yi∂yj
[ΣijP (Y, t)] ,
P (Y, 0) = δ7(Y−Y0).
By solving this PDE, one can find the probability density function of our model, but since this
equation is high-dimensional and nonlinear, solving it analytically is impossible. Hence, we use another
approach, a so-called system size expansion or van Kampen’s Ω-expansion [57], which is a method for
constructing a continuous approximation to a discrete stochastic model [36, 37], which allows one to
study stochastic fluctuations around deterministic attractors [59].
2.3 System size expansion
In order to apply the van Kampen’s approach, we consider fluctuations within a systematic expansion
of the master equation for a large system size Ω. Specifically, we write each ni(t) as a deterministic
part of order Ω plus a fluctuation of order Ω1/2 as follows,
ni(t) = Ωxi(t) + Ω
1/2ζi(t), i = 1, . . . , 7, (5)
where xi(t) and ζi(t) are two continuous variables, and Ωxi(t) = E[ni(t)]. The probability density
P (n, t) satisfying the master equation (3) is now represented by the probability density Π(ζ, t), i.e.
Π(ζ, t) = P (n, t) = P
(
Ωx+ Ω1/2ζ, t
)
, which implies
dP (n, t)
dt
=
∂Π
∂t
−
7∑
i=1
Ω1/2
dxi
dt
∂Π
∂ζi
. (6)
To expand the master equation (3) in a power series in Ω−1/2, we use the following expansion for the
step operators
ε±i = 1± Ω−1/2
∂
∂ζi
+
1
2
Ω−1
∂2
∂ζ2i
± · · · . (7)
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Substituting expressions (6) and (7) into the master equation (see Supplementary Material for
details) and collecting terms of order Ω1/2 yields the following deterministic model for macroscopic
behaviour
dx1
dt
= b1x1 + b˜2x
2
1 − d1x1 − d˜2x21 − β˜x1x2 − µ˜ax1x6,
dx2
dt
= β˜x1x2 − dFx2 − µ˜Fx2x5 − µ˜ax2x6,
dx3
dt
= λ˜in − dinx3 − α˜x2x3,
dx4
dt
= λ˜r − drx4 + p1α˜x2x3 + ρ˜1x4x7,
dx5
dt
= p2α˜x2x3 − dnx5 + ρ˜2x5x7,
dx6
dt
= (1− p1 − p2)α˜x2x3 − dax6 − δ˜x4x6 + ρ˜3x6x7,
dx7
dt
= σ1x5 + σ2x6 − dix7,
(8)
where
b2 =
b˜2
Ω
, d2 =
d˜2
Ω
, β =
β˜
Ω
, µa =
µ˜a
Ω
, µF =
µ˜F
Ω
, α =
α˜
Ω
, δ =
δ˜
Ω
,
ρi =
ρ˜i
Ω
, i = 1, 2, 3, λin = λ˜inΩ, λr = λ˜rΩ.
Model (8) has been analysed in (Fatehi et al. 2017), and it can have at most four biologically
feasible steady states. The first one, a disease-free steady state, is given by
S∗1 =
(
b1 − d1
d˜2 − b˜2
, 0,
λ˜in
din
,
λ˜r
dr
, 0, 0, 0
)
,
and it is stable if dF > β˜. The second and third steady states can be found as
S∗2 =
0, 0, λ˜in
din
, x∗4, 0,
di
(
da + δ˜x
∗
4
)
ρ˜3σ2
,
da + δ˜x
∗
4
ρ˜3
 ,
and
S∗3 =
 ρ˜3σ2(b1 − d1)− µ˜adi
(
da + δ˜x
∗
4
)
ρ˜3σ2
(
d˜2 − b˜2
) , 0, λ˜in
din
, x∗4, 0,
di
(
da + δ˜x
∗
4
)
ρ˜3σ2
,
da + δ˜x
∗
4
ρ˜3
 ,
where x∗4 satisfies the following quadratic equation
ρ˜1δ˜ (x
∗
4)
2 + (ρ˜1da − ρ˜3dr)x∗4 + ρ˜3λ˜r = 0. (9)
These steady states are stable, provided
σ2
µ˜adi
K <
da + δ˜x
∗
4
ρ˜3
<
dn
ρ˜2
, δ˜ρ˜1(x
∗
4)
2 > λ˜rρ˜3,
ρ˜3λ˜
2
r + ρ˜3diλ˜rx
∗
4 − ρ˜3dida(x∗4)2 − δ˜(ρ˜1da + ρ˜3di)(x∗4)3 − ρ˜1δ˜2(x∗4)4 > 0,
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where K = 1 for S∗2 , and K =
(
β˜ − dF
)
/
(
1 + β˜
)
for S∗3 . Biologically, the steady state S∗2 represents
the death of organ cells, while S∗3 corresponds to an autoimmune regime.
The last steady state S∗4 has all of its components positive and corresponds to the state of chronic
infection.
At the next order, stochastic fluctuations are determined by linear stochastic processes, hence, this
is known as a linear noise approximation [57, 60]. The dynamics of these fluctuations is described by
the following linear Fokker-Planck equation
∂Π(ζ, t)
∂t
= −
∑
i,j
Aij
∂
∂ζi
(ζjΠ) +
1
2
∑
i,j
Bij
∂2Π
∂ζi∂ζj
, (10)
where A is the Jacobian matrix of system (8)
A =

b1 + 2b˜2x1 − d1 − 2d˜2x1 − µ˜ax6 − β˜x2 −β˜x1 0 0 0 −µ˜ax1 0
β˜x2 β˜x1 − dF − µ˜Fx5 − µ˜ax6 0 0 −µ˜Fx2 −µ˜ax2 0
0 −α˜x3 −din − α˜x2 0 0 0 0
0 p1α˜x3 p1α˜x2 ρ˜1x7 − dr 0 0 ρ˜1x4
0 p2α˜x3 p2α˜x2 0 ρ˜2x7 − dn 0 ρ˜2x5
0 (1− p1 − p2)α˜x3 (1− p1 − p2)α˜x2 −δ˜x6 0 ρ˜3x7 − da − δ˜x4 ρ˜3x6
0 0 0 0 σ1 σ2 −di

,
and B is a 7× 7 symmetric matrix given by
Bij =

b1x1 + b˜2x
2
1 + d1x1 + d˜2x
2
1 + β˜x1x2 + µ˜ax1x6, if (i, j) = (1, 1),
β˜x1x2 + dFx2 + µ˜Fx2x5 + µ˜ax2x6, if (i, j) = (2, 2),
λ˜in + dinx3 + α˜x2x3, if (i, j) = (3, 3),
λ˜r + drx4 + p1α˜x2x3 + ρ˜1x4x7, if (i, j) = (4, 4),
p2α˜x2x3 + dnx5 + ρ˜2x5x7, if (i, j) = (5, 5),
(1− p1 − p2)α˜x2x3 + dax6 + δ˜x4x6 + ρ˜3x6x7, if (i, j) = (6, 6),
σ1x5 + σ2x6 + dix7, if (i, j) = (7, 7),
−β˜x1x2, if (i, j) = (1, 2) or (2, 1),
−p1α˜x2x3, if (i, j) = (3, 4) or (4, 3),
−p2α˜x2x3, if (i, j) = (3, 5) or (5, 3),
−(1− p1 − p2)α˜x2x3, if (i, j) = (3, 6) or (6, 3),
0, otherwise.
Since the Fokker-Planck equation (10) is linear, the probability density Π(ζ, t) is Gaussian, and hence,
just the first two moments are enough to characterise it [61, 62]. Due to the way the system size
expansion was introduced in (5), the mean values of fluctuations for all variables are zero, i.e. 〈ζi(t)〉 =
0 for all 1 ≤ i ≤ 7, while the covariance matrix Ξ with Ξij = 〈ζi(t)ζj(t)〉 − 〈ζi(t)〉〈ζj(t)〉 = 〈ζi(t)ζj(t)〉
satisfies the following equation [57, 62]
∂tΞ = AΞ + ΞA
T +B, (11)
where AT is the transpose of A.
We are mainly interested in the dynamics of fluctuations when the oscillations of the deterministic
model have died out, and the system is in a stationary state, i.e. the fluctuations take place around
the steady states [59]. If the model (8) tends to a steady state as t → ∞, then in the equation (10)
one can substitute the values of xi’s with the corresponding constant components of that steady state
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Table 2: Table of parameters
Parameter value Parameter value
b1 2.5 dr 0.8
b˜2 0.1 p1 0.4
d1 0.5 ρ˜1 10/9
d˜2 0.2 p2 0.4
β˜ 0.1 dn 2
µ˜a 40/9 ρ˜2 4/45
dF 2.2 da 0.002
µ˜F 4/3 δ˜ 1/4500
λ˜in 18 ρ˜3 2/9
din 2 σ1 0.3
α˜ 0.04 σ2 0.4
λ˜r 108 di 1.2
to study the fluctuations around it, as described by the linear Fokker-Planck equation. At any steady
state, the covariance matrix Ξ is independent of time, and the fluctuations are described by a Gaussian
distribution with the zero mean and the stationary covariance satisfying the equation
AΞ + ΞAT +B = 0.
In order to be able to relate the results of this analysis to simulations, it is convenient to express the
covariance matrix in terms of actual numbers of cells in each compartment, rather than deviations from
stationary values. To this end, we instead use the covariance matrix C defined as Cij = 〈(ni−〈ni〉)(nj−
〈nj〉)〉, which, in light of the relation Cij = ΩΞij , satisfies the following Lyapunov equation [62]
AC + CAT + ΩB = 0. (12)
This equation can be solved numerically for each of the stable steady states to determine the variance
of fluctuations around that steady state depending on system parameters.
3 Results
To simulate the dynamics of the model, we solve the system (4) numerically using the Euler-Maruyama
method with parameter values given in Table 2, and Ω = 1000. The initial condition is chosen to be
of the form
(x1(0), x2(0), x3(0), x4(0), x5(0), x6(0), x7(0)) = (18, 2, 7.2, 6.3, 0, 0, 0), (13)
which corresponds to a small number of host cells being initially infected.
Figure 2 shows the results of 20000 simulations with the initial condition (13) and σ2 = 1. In the
deterministic model (8), for σ2 = 1 both steady states S
∗
1 (disease-free) and S
∗
3 (autoimmune state) are
stable, but with the initial condition (13) the system is in the basin of attraction of S∗3 . In the stochastic
model, the majority of trajectories also enter the attraction region of S∗3 , but a small proportion of
them went into the basin of attraction of S∗1 . This figure illustrates a single stochastic path around S∗1 ,
and a single stochastic path around S∗3 , together with the deterministic trajectory. These individual
solutions indicate that whilst deterministically, the system exhibits decaying oscillations around S∗3 ,
the same behaviour is observed in the stochastic simulations only upon taking an average of a very
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Figure 2: Numerical simulation of the model (4) with parameter values from Table 2, σ2 = 1, and
the initial condition (13). Red curves are two sample paths that have entered the basins of attraction
of S∗1 or S∗3 , black curve is the deterministic trajectory from (1), and the shaded areas indicate the
regions of one standard deviation from the mean.
large number of simulations. At the same time, individual realisations exhibit sustained stochastic
oscillations in a manner similar to that observed in models of stochastic amplification in epidemics [39,
40]. Figure 2 also illustrates the size of areas of one standard deviation from the mean for trajectories
in the basins of attraction S∗1 and S∗3 , in which individual stochastic trajectories may exhibit stochastic
oscillations [63, 38].
Figures 3A and B show temporal evolution of the probability distribution in the case of bi-stability
between the steady states S∗1 and S∗3 , as illustrated in Figure 2. They indicate that after some initial
transient, the system reaches a stationary bimodal normal distribution. The width of the probability
distribution around each stable steady state, as described by its variance or standard deviation, gives
the size of fluctuations around this steady state observed in individual stochastic realisations, as is
shown in Fig. 2. Similar behaviour has been observed in stochastic realisations of other deterministic
models with bi-stability [64, 65, 66]. For the parameter values given in Table 2, the deterministic
system exhibits a bi-stability between S∗1 and S∗2 , and with the initial condition
(x1(0), x2(0), x3(0), x4(0), x5(0), x6(0), x7(0)) = (18, 9, 7.2, 6.3, 0, 0, 0), (14)
it is in the basin of attraction of S∗2 . Due to stochasticity, the stationary probability distribution in
this case is also bimodal, with the majority of solutions being distributed around S∗2 , and a very small
number being centred around S∗1 , as can be seen in Figures 3C and D. Increasing the system size Ω is
known to result in the bimodal distribution becoming unimodal due to the size of fluctuations scaling
as Ω−1/2, which results in a reduced variability in trajectories [67, 66], and the same conclusion holds
for the system (4).
To gain better insights into the role of initial conditions, in Figure 4 we fix all parameter values,
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Figure 3: Probability distribution of solutions out of 20000 simulations. (A) and (B) with parameters
from Table 2, but σ2 = 1 and the initial condition (13). (C) and (D) with parameters from Table 2
and the initial condition (14). In (A) and (C), the probability histogram is fit to a bimodal normal
distribution at different times. (B) and (D) illustrate stationary joint probability histograms.
and vary initial numbers of infected cells and regulatory T cells. For the parameter combination
illustrated in Figure 4A, the deterministic model exhibits a bi-stability between a stable disease-free
steady state S∗1 and a periodic oscillation around the state S∗3 , which biologically corresponds to an
autoimmune regime. In the deterministic case, the black boundary provides a clear separation of the
basins of attraction of these two dynamical states, in a manner similar to that investigated recently
in the context of within-cell dynamics of RNA interference [68]. For stochastic simulations, the colour
indicates the probability of the solution going to a disease-free state S∗1 , and it shows that even in
the case where deterministically the system is in the basin of attraction of one of the states, there
is a non-zero probability that it will actually end up at another state, with this probability varying
smoothly across the deterministic basin boundary. This figure suggests that if the initial number of
infected cells is sufficiently small, or if the number of regulatory T cells is sufficiently large, the system
tends to clear the infection and approach the disease-free state. On the contrary, for higher numbers
of infected cells and lower numbers of regulatory cells, autoimmune regime appears to be a more likely
outcome. Qualitatively similar behaviour is observed for another combination of parameters illustrated
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Figure 4: Probability of solution entering and staying in the basin of attraction of the disease-free
steady state S∗1 in the bi-stability regime with A(0) = 18000 and Tin(0) = 7200. Black curves are
the boundaries between different basins of attraction in the deterministic model. (A) With parameter
values from Table 2, λ˜r = 45 and µ˜a = 10/9, in the region below the black curve, the deterministic
model exhibits a periodic solution around S∗3 , and above this curve is the deterministic basin of
attraction of S∗1 . (B) With parameter values from Table 2, area below the black curve is the basin of
attraction of S∗2 , and above it is again the basin of attraction of S∗1 .
in Figure 4B, in which case the deterministic system has a bi-stability between a disease-free steady
state S∗1 , and a state S∗2 which represents the death of host cells.
In order to understand how biological parameters affect the size of fluctuations around steady
states, in Figure 5 we explore several parameter planes by first identifying parameter regions where
the deterministic system has a stable steady state S∗3 , and then for each combination of parameters
inside these regions, we use the Bartels-Stewart method [69, 70] to numerically solve the Lyapunov
equation (12) and compute the variance in the number of regulatory T cell when the deterministic
model is at the steady state S∗3 . The value of variance gives the square of the magnitude of oscillations
observed in individual stochastic realisations. One should note that getting closer to the deterministic
boundary of stability of S∗3 increases the stochastic variance of fluctuations around this steady state.
The reason for this is that closer parameters are to the deterministic stability boundary, the less stable
is the steady state, hence the larger is the amplitude of stochastic oscillations around it. Moreover,
the variance increases with the rate of production of IL-2 by autoreactive T cells and the rate at which
regulatory T cells suppress autoreactive T cells; it decreases with the higher rate of production of
regulatory T cells, and it appears to not depend on the rate at which autoreactive T cells destroy
infected cells, or on the infection rate.
4 Discussion
In this paper we have analysed stochastic aspects of immune response against a viral infection with
account for the populations of T cells with different activation thresholds, as well as cytokines medi-
ating T cell activity. The CTMC model has provided an exact master equation, for which we applied
a van Kampen’s expansions to derive a linear Fokker-Planck equation that characterises fluctuations
around the deterministic solutions. We have also explored actual stochastic trajectories of the system
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Figure 5: Variance of the number of regulatory T cells Treg with parameter values from Table 2.
Coloured regions indicate areas in respective parameter planes in which the autoimmune steady state
S∗3 is deterministically stable.
by deriving an SDE model and solving it numerically.
One biologically important aspect we have looked at is the influence of stochasticity on the dynam-
ics of the system in the case where deterministically it exhibits a bi-stability between either two steady
states, or a steady state and a periodic solution. In such a situation, bi-stability in the deterministic
version of the model translates in the stochastic case into a stationary bimodal distribution for the
probability density. To obtain further insights into details of how stochasticity affects bi-stability, we
have investigated how for the fixed parameter values time evolution of the system changes depending
on the initial numbers of the regulatory T cells and infected cells.
Our analysis reinforces the need to distinguish mean dynamics from individuals realisations: where
in the deterministic case the system can approach a stable steady state (which represents mean be-
haviour of a very large number of simulations), individual realisations can exhibit sustained stochastic
oscillations around that steady state, as we have seen in numerical simulations. Since in the clini-
cal or laboratory setting one is usually dealing with single measurements of some specific biological
quantities rather than their averaged values, the stochastic oscillations exhibited by our model may
quite well explain observed variability in the measured levels of infection or T cell populations. To
better understand the magnitude of stochastic fluctuations around the deterministic steady states, we
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have solved the Lyapunov equation, which has provided us with a quantitative information on the
dependence of variance of fluctuations on system parameters.
There are several directions in which the work presented in this paper can be extended. In terms
of fundamental immunology, the model can be made more realistic by including additional effects,
such as the control of IL-2 secretion by regulatory T cells [71], or the memory T cells [72, 73]. Whilst
we have used numerical simulations to compute the probability of attraction to a given steady state
in the case of bi-stability, one could approach the same problem theoretically from the perspective
of computing extinction probability within the framework of the CTMC model [50, 74]. The van
Kampen’s system size expansion could yield an expression for the power spectrum, which allows
one to compute the peak frequency and amplification [59, 75, 76, 39]. From a practical perspective,
future work could focus on validating theoretical results presented in this paper using experimental
measurements of the progress of autoimmune disease in animal hosts, with experimental autoimmune
uveoretinitis (EAU), an autoimmune inflammation in the eyes, being one interesting possibility. In
one such recent experiment, all animals were genetically identical C57BL/6 mice, but once the EAU
was induced in them through inoculation, the autoimmune disease then progressed at slightly different
rates [77], (Boldison and Nicholson, 2012) and the measured variability in the numbers of infected cells
and T cell responses could be compared to theoretical estimates of the variance as predicted by our
model. From a clinical perspective, comparison of variance in the measured populations of different
cells with the model conclusions will facilitate an efficient parameter identification and provide a set
of prognostic criteria for the progress of autoimmunity, which can be used for risk stratification and
assessment of patients with autoimmune disease.
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5 Supplementary Material
Derivation of the van Kampen’s system size expansion
As described in Section 2.2 of the main text, the CTMC model based on the transitions probabilities
yields the following master equation:
dP (n, t)
dt
={(ε−1 − 1)q1 + (ε+1 − 1)q2 + (ε+1 ε−2 − 1)q3 + (ε−3 − 1)q4 + (ε+3 − 1)q5
+ (ε+3 ε
−
4 − 1)q6 + (ε+3 ε−5 − 1)q7 + (ε+3 ε−6 − 1)q8 + (ε+2 − 1)q9 + (ε−4 − 1)q10
+ (ε+4 − 1)q11 + (ε−5 − 1)q12 + (ε+5 − 1)q13 + (ε−6 − 1)q14 + (ε+6 − 1)q15
+ (ε−7 − 1)q16 + (ε+7 − 1)q17}P (n, t), (15)
where n = (n1, n2, n3, n4, n5, n6, n7) is the current state of the system, the coefficients qi are given by
q1 = b1n1 + b2n
2
1, q2 = d1n1 + d2n
2
1 + µan6n1, q3 = βn1n2, q4 = λin,
q5 = dinn3, q6 = p1αn3n2, q7 = p2αn3n2, q8 = (1− p1 − p2)αn3n2,
q9 = (dF + µFn5 + µan6)n2, q10 = λr + ρ1n7n4, q11 = drn4, q12 = ρ2n7n5,
q13 = dnn5, q14 = ρ3n7n6, q15 = (da + δn4)n6, q16 = σ1n5 + σ2n6, q17 = din7,
and the operators ε±i are defined as follows,
ε±i f(n1, n2, n3, n4, n5, n6, n7, t) = f(n1, ..., ni ± 1, ..., n7, t), 1 ≤ i ≤ 7.
If ni < 0 for any 1 ≤ i ≤ 7, then P (n, t) = 0.
To derive the van Kampen’s system size expansion of the master equation (3), we rewrite each
ni(t) in the form
ni(t) = Ωxi(t) + Ω
1/2ζi(t), 1 ≤ i ≤ 7,
where Ωxi(t) = E[ni(t)], so ζi(t) represent the fluctuations. Replacing the probability density P (n, t)
by the equivalent probability density Π(ζ, t), i.e. with Π(ζ, t) = P (n, t) = P
(
Ωx+ Ω1/2ζ, t
)
, the
left-hand side of the master equation (3) transforms into
dP (n, t)
dt
=
∂Π
∂t
−
7∑
i=1
Ω1/2
dxi
dt
∂Π
∂ζi
. (16)
The operators ε±i and their product now satisfy the following expansions
ε±i = 1± Ω−1/2
∂
∂ζi
+
1
2
Ω−1
∂2
∂ζ2i
± · · · ,
ε+i ε
−
j =
(
1 + Ω−1/2
∂
∂ζi
+
1
2
Ω−1
∂2
∂ζ2i
+ · · ·
)(
1− Ω−1/2 ∂
∂ζj
+
1
2
Ω−1
∂2
∂ζ2j
− · · ·
)
= 1 + Ω−1/2
(
∂
∂ζi
− ∂
∂ζj
)
+ Ω−1
(
1
2
∂2
∂ζ2i
− ∂
2
∂ζi∂ζj
+
1
2
∂2
∂ζ2j
)
+ · · ·, 1 ≤ i, j ≤ 7.
(17)
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One can easily obtain/introduce Ω-expansions for all parameters qi:
q1 = b1n1 + b2n
2
1 = b1
(
Ωx1 + Ω
1/2ζ1
)
+ b2
(
Ω2x21 + Ωζ
2
1 + 2Ω
3/2x1ζ1
)
= b1
(
Ωx1 + Ω
1/2ζ1
)
+ b2Ω︸︷︷︸
b˜2
(
Ωx21 + ζ
2
1 + 2Ω
1/2x1ζ1
)
= b˜2ζ
2
1 +
(
b1ζ1 + 2b˜2x1ζ1
)
Ω1/2 +
(
b1x1 + b˜2x
2
1
)
Ω,
q2 = d1n1 + d2n
2
1 + µan6n1
= d1
(
Ωx1 + Ω
1/2ζ1
)
+ d2
(
Ω2x21 + Ωζ
2
1 + 2Ω
3/2x1ζ1
)
+ µa
(
Ωx1 + Ω
1/2ζ1
)(
Ωx6 + Ω
1/2ζ6
)
= d1
(
Ωx1 + Ω
1/2ζ1
)
+ d2Ω︸︷︷︸
d˜2
(
Ωx21 + ζ
2
1 + 2Ω
1/2x1ζ1
)
+ µaΩ︸︷︷︸
µ˜a
(
Ω1/2x1 + ζ1
)(
Ω1/2x6 + ζ6
)
= d1
(
Ωx1 + Ω
1/2ζ1
)
+ d˜2
(
Ωx21 + ζ
2
1 + 2Ω
1/2x1ζ1
)
+ µ˜a
(
Ωx1x6 + Ω
1/2x1ζ6 + Ω
1/2x6ζ1 + ζ1ζ6
)
= µ˜aζ1ζ6 +
(
d1ζ1 + 2d˜2x1ζ1 + µ˜ax1ζ6 + µ˜ax6ζ1
)
Ω1/2 +
(
d1x1 + d˜2x
2
1 + µ˜ax1x6
)
Ω,
q3 = βn1n2 = β
(
Ωx1 + Ω
1/2ζ1
)(
Ωx2 + Ω
1/2ζ2
)
= βΩ︸︷︷︸
β˜
(
Ω1/2x1 + ζ1
)(
Ω1/2x2 + ζ2
)
= β˜
(
Ωx1x2 + Ω
1/2x1ζ2 + Ω
1/2x2ζ1 + ζ1ζ2
)
= β˜ζ1ζ2 +
(
β˜x1ζ2 + β˜x2ζ1
)
Ω1/2 + β˜x1x2Ω,
q4 = λin =
λin
Ω︸︷︷︸
λ˜in
Ω = λ˜inΩ,
q5 = dinn3 = din
(
Ωx3 + Ω
1/2ζ3
)
= dinζ3Ω
1/2 + dinx3Ω,
In a similar way we can easily show
q6 = p1α˜ζ2ζ3 + (p1α˜x2ζ3 + p1α˜x3ζ2) Ω
1/2 + p1α˜x2x3Ω,
q7 = p2α˜ζ2ζ3 + (p2α˜x2ζ3 + p2α˜x3ζ2) Ω
1/2 + p2α˜x2x3Ω,
q8 = (1− p1 − p2)
[
α˜ζ2ζ3 + α˜x2ζ3 + α˜x3ζ2Ω
1/2 + α˜x2x3Ω
]
,
q9 = (µ˜F ζ2ζ5 + µ˜aζ2ζ6) + (dF + µ˜Fx2ζ5 + µ˜Fx5ζ2 + µ˜ax2ζ6 + µ˜ax6ζ2) Ω
1/2
+ (dFx2 + µ˜Fx2x5 + µ˜ax2x6) Ω,
q10 = ρ˜1ζ4ζ7 + (ρ˜1x4ζ7 + ρ˜1x7ζ4) Ω
1/2 +
(
λ˜r + ρ˜1x4x7
)
Ω,
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q11 = drζ4Ω
1/2 + drx4Ω, q12 = ρ˜2ζ5ζ7 + (ρ˜2x5ζ7 + ρ˜2x7ζ5) Ω
1/2 + ρ˜2x5x7Ω,
q13 = dnζ5Ω
1/2 + dnx5Ω, q14 = ρ˜3ζ6ζ7 + (ρ˜3x6ζ7 + ρ˜3x7ζ6) Ω
1/2 + ρ˜3x6x7Ω,
q15 = δ˜ζ4ζ6 +
(
daζ6 + δ˜x4ζ6 + δ˜x6ζ4
)
Ω1/2 +
(
dax6 + δ˜x4x6
)
Ω,
q16 = (σ1ζ5 + σ2ζ6) Ω
1/2 + (σ1x5 + σ2x6)Ω, q17 = diζ7Ω
1/2 + dix5Ω,
where
λr = λ˜rΩ, µF =
µ˜F
Ω
, α =
α˜
Ω
, δ =
δ˜
Ω
, ρi =
ρ˜i
Ω
, i = 1, 2, 3.
Substituting expressions (16), (17) and qi’s into the master equation (3) shows that the left-hand side
of the equation only contains terms of the order Ω1/2 and Ω0, while the right-hand side has terms of
the order Ω1/2, Ω0, and Ω−n/2, for n ∈ N. To derive a linear Fokker-Planck equation, we ignore the
terms of order Ω−n/2, for n ∈ N.
Considering the terms of order Ω1/2, i.e. only the terms that are proportional to ∂Π/∂ζi, yields
−Ω1/2dx1
dt
∂Π
∂ζ1
=
(
−Ω−1/2 ∂
∂ζ1
)[(
b1x1 + b˜2x
2
1
)
Ω
]
Π +
(
Ω−1/2
∂
∂ζ1
)[(
d1x1 + d˜2x
2
1 + µ˜ax1x6
)
Ω
]
Π
+
(
Ω−1/2
∂
∂ζ1
)[
β˜x1x2Ω
]
Π,
−Ω1/2dx2
dt
∂Π
∂ζ2
=
(
−Ω−1/2 ∂
∂ζ2
)[
β˜x1x2Ω
]
Π +
(
Ω−1/2
∂
∂ζ2
)
[(dFx2 + µ˜Fx2x5 + µ˜ax2x6) Ω] Π,
−Ω1/2dx3
dt
∂Π
∂ζ3
=
(
−Ω−1/2 ∂
∂ζ3
)[
λ˜inΩ
]
Π +
(
Ω−1/2
∂
∂ζ3
)
[dinx3Ω] Π +
(
Ω−1/2
∂
∂ζ3
)
[p1α˜x2x3Ω] Π(
Ω−1/2
∂
∂ζ3
)
[p2α˜x2x3Ω] Π +
(
Ω−1/2
∂
∂ζ3
)
[(1− p1 − p2)α˜x2x3Ω] Π,
−Ω1/2dx4
dt
∂Π
∂ζ4
=
(
−Ω−1/2 ∂
∂ζ4
)
[p1α˜x2x3Ω] Π +
(
−Ω−1/2 ∂
∂ζ4
)[(
λ˜r + ρ˜1x4x7
)
Ω
]
Π
+
(
Ω−1/2
∂
∂ζ4
)
[drx4Ω] Π,
−Ω1/2dx5
dt
∂Π
∂ζ5
=
(
−Ω−1/2 ∂
∂ζ5
)
[p2α˜x2x3Ω] Π +
(
−Ω−1/2 ∂
∂ζ5
)
[ρ˜2x5x7Ω] Π
−
(
Ω−1/2
∂
∂ζ5
)
[dnx5Ω] Π,
−Ω1/2dx6
dt
∂Π
∂ζ6
=
(
−Ω−1/2 ∂
∂ζ6
)
[(1− p1 − p2)α˜x2x3Ω] Π +
(
−Ω−1/2 ∂
∂ζ6
)
[ρ˜3x6x7Ω] Π
+
(
Ω−1/2
∂
∂ζ6
)[(
dax6 + δ˜x4x6
)
Ω
]
Π,
−Ω1/2dx7
dt
∂Π
∂ζ7
=
(
−Ω−1/2 ∂
∂ζ7
)
[(σ1x5 + σ2x6)Ω] Π +
(
Ω−1/2
∂
∂ζ7
)
[dix5Ω] Π.
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After simplification, we obtain the following system of equations that describes macroscopic behaviour
of the model
dx1
dt
= b1x1 + b˜2x
2
1 − d1x1 − d˜2x21 − β˜x1x2 − µ˜ax1x6,
dx2
dt
= β˜x1x2 − dFx2 − µ˜Fx2x5 − µ˜ax2x6,
dx3
dt
= λ˜in − dinx3 − α˜x2x3,
dx4
dt
= λ˜r − drx4 + p1α˜x2x3 + ρ˜1x4x7,
dx5
dt
= p2α˜x2x3 − dnx5 + ρ˜2x5x7,
dx6
dt
= (1− p1 − p2)α˜x2x3 − dax6 − δ˜x4x6 + ρ˜3x6x7,
dx7
dt
= σ1x5 + σ2x6 − dix7.
(18)
Terms of order Ω0 give the following Fokker-Planck equation
∂Π
∂t
= −
[(
b1 + 2b˜2x1 − d1 − 2d˜2x1 − µ˜ax6 − β˜x2
) ∂(ζ1Π)
∂ζ1
− β˜x1∂(ζ2Π)
∂ζ1
− µ˜ax1∂(ζ6Π)
∂ζ1
+ β˜x2
∂(ζ1Π)
∂ζ2
+
(
β˜x1 − dF − µ˜Fx5 − µ˜ax6
) ∂(ζ2Π)
∂ζ2
− µ˜Fx2∂(ζ5Π)
∂ζ2
− µ˜ax2∂(ζ6Π)
∂ζ2
− α˜x3∂(ζ2Π)
∂ζ3
− (din + α˜x2) ∂(ζ3Π)
∂ζ3
+ p1α˜x3
∂(ζ2Π)
∂ζ4
+ p1α˜x2
∂(ζ3Π)
∂ζ4
+ (ρ˜1x7 − dr) ∂(ζ4Π)
∂ζ4
+ ρ˜1x4
∂(ζ7Π)
∂ζ4
+ p2α˜x3
∂(ζ2Π)
∂ζ5
+ p2α˜x2
∂(ζ3Π)
∂ζ5
+ (ρ˜2x7 − dn) ∂(ζ5Π)
∂ζ5
+ ρ˜2x5
∂(ζ7Π)
∂ζ5
+ (1− p1 − p2)α˜x3∂(ζ2Π)
∂ζ6
+ (1− p1 − p2)α˜x2∂(ζ3Π)
∂ζ6
− δ˜x6∂(ζ4Π)
∂ζ6
+
(
ρ˜3x7 − da − δ˜
)
x4
∂(ζ6Π)
∂ζ6
+ ρ˜3x6
∂(ζ7Π)
∂ζ6
+ σ1
∂(ζ5Π)
∂ζ7
+ σ2
∂(ζ6Π)
∂ζ7
− di∂(ζ7Π)
∂ζ7
]
+
1
2
{(
b1x1 + b˜2x
2
1 + d1x1 + d˜2x
2
1 + β˜x1x2 + µ˜ax1x6
) ∂2Π
∂ζ21
− 2β˜x1x2 ∂
2Π
∂ζ1∂ζ2
+
(
β˜x1x2 + dFx2 + µ˜Fx2x5 + µ˜ax2x6
) ∂2Π
∂ζ22
+
(
λ˜in + dinx3 + α˜x2x3
) ∂2Π
∂ζ23
− 2p1α˜x2x3 ∂
2Π
∂ζ3∂ζ4
− 2p2α˜x2x3 ∂
2Π
∂ζ3∂ζ5
− 2(1− p1 − p2)α˜x2x3 ∂
2Π
∂ζ3∂ζ6
+
(
λ˜r + drx4 + p1α˜x2x3 + ρ˜1x4x7
) ∂2Π
∂ζ24
+ (p2α˜x2x3 + dnx5 + ρ˜2x5x7)
∂2Π
∂ζ25
+
[
(1− p1 − p2)α˜x2x3 + dax6 + δ˜x4x6 + ρ˜3x6x7
] ∂2Π
∂ζ26
+ (σ1x5 + σ2x6 + dix7)
∂2Π
∂ζ27
}
.
This equation can be equivalently rewritten in the form
∂Π(ζ, t)
∂t
= −
∑
i,j
Aij
∂
∂ζi
(ζjΠ) +
1
2
∑
i,j
Bij
∂2Π
∂ζi∂ζj
,
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where A is the Jacobian matrix of system (18)
A =

b1 + 2b˜2x1 − d1 − 2d˜2x1 − µ˜ax6 − β˜x2 −β˜x1 0 0 0 −µ˜ax1 0
β˜x2 β˜x1 − dF − µ˜Fx5 − µ˜ax6 0 0 −µ˜Fx2 −µ˜ax2 0
0 −α˜x3 −din − α˜x2 0 0 0 0
0 p1α˜x3 p1α˜x2 ρ˜1x7 − dr 0 0 ρ˜1x4
0 p2α˜x3 p2α˜x2 0 ρ˜2x7 − dn 0 ρ˜2x5
0 (1− p1 − p2)α˜x3 (1− p1 − p2)α˜x2 −δ˜x6 0 ρ˜3x7 − da − δ˜x4 ρ˜3x6
0 0 0 0 σ1 σ2 −di

B is a 7× 7 symmetric matrix given by
Bij =

b1x1 + b˜2x
2
1 + d1x1 + d˜2x
2
1 + β˜x1x2 + µ˜ax1x6, if (i, j) = (1, 1),
β˜x1x2 + dFx2 + µ˜Fx2x5 + µ˜ax2x6, if (i, j) = (2, 2),
λ˜in + dinx3 + α˜x2x3, if (i, j) = (3, 3),
λ˜r + drx4 + p1α˜x2x3 + ρ˜1x4x7, if (i, j) = (4, 4),
p2α˜x2x3 + dnx5 + ρ˜2x5x7, if (i, j) = (5, 5),
(1− p1 − p2)α˜x2x3 + dax6 + δ˜x4x6 + ρ˜3x6x7, if (i, j) = (6, 6),
σ1x5 + σ2x6 + dix7, if (i, j) = (7, 7),
−β˜x1x2, if (i, j) = (1, 2) or (2, 1),
−p1α˜x2x3, if (i, j) = (3, 4) or (4, 3),
−p2α˜x2x3, if (i, j) = (3, 5) or (5, 3),
−(1− p1 − p2)α˜x2x3, if (i, j) = (3, 6) or (6, 3),
0, otherwise.
27
